Literature DB >> 27508048

MiR-338-3p targets pyruvate kinase M2 and affects cell proliferation and metabolism of ovarian cancer.

Yuting Zhang1, Bing Shi2, Jiang Chen3, Lina Hu4, Chunquan Zhao5.   

Abstract

MiR-338-3p is down-regulated in cancer, which inhibits cancer cell proliferation, metastasis, and increases chemosensitivity, but its functions in ovarian cancer remains unknown. The present study aims to identify the miR-338-3p targeted genes and to investigate the associated regulatory mechanisms in ovarian cancer cell proliferation and metabolism. Our results demonstrated miR-338-3p expression was down-regulated in most of ovarian cancer tissues and cell lines. Restoration of miR-338-3p expression in ovarian cancer cells could inhibit cell proliferation, lactate production and lactate production of ovarian cancer cells. PKM2 was verified as a target gene of miR-338-3p by luciferase assay. Further study indicated miR-338-3p controlled ovarian cancer cell metabolism by inhibiting PKM2 expression. It is summarized that the regulatory role of miR-338-3p on PKM2 expression in ovarian cancer may play important roles in cell metabolism.

Entities:  

Keywords:  MiR-338-3p; PKM2; metabolism; ovarian cancer; proliferation

Year:  2016        PMID: 27508048      PMCID: PMC4969464     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  23 in total

Review 1.  Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.

Authors:  Mayumi Tamada; Makoto Suematsu; Hideyuki Saya
Journal:  Clin Cancer Res       Date:  2012-10-15       Impact factor: 12.531

Review 2.  Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.

Authors:  Barbara Chaneton; Eyal Gottlieb
Journal:  Trends Biochem Sci       Date:  2012-05-23       Impact factor: 13.807

Review 3.  Regulation and function of pyruvate kinase M2 in cancer.

Authors:  Weiwei Yang; Zhimin Lu
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

4.  microRNA-338-3p functions as a tumor suppressor in human non‑small‑cell lung carcinoma and targets Ras-related protein 14.

Authors:  Jiangtao Sun; Xiaoshang Feng; Shegan Gao; Zhongyue Xiao
Journal:  Mol Med Rep       Date:  2014-11-06       Impact factor: 2.952

5.  Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.

Authors:  Qian Sun; Xinxin Chen; Jianhui Ma; Haiyong Peng; Fang Wang; Xiaojun Zha; Yanan Wang; Yanling Jing; Hongwang Yang; Rongrong Chen; Long Chang; Yu Zhang; June Goto; Hiroaki Onda; Tong Chen; Ming-Rong Wang; Youyong Lu; Han You; David Kwiatkowski; Hongbing Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

Review 6.  MicroRNAs in ovarian carcinomas.

Authors:  Neetu Dahiya; Patrice J Morin
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

7.  miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.

Authors:  Xin Chen; Min Pan; Lulu Han; Hongting Lu; Xiwei Hao; Qian Dong
Journal:  FEBS Lett       Date:  2013-10-15       Impact factor: 4.124

Review 8.  Regulation of Metastasis by microRNAs in Ovarian Cancer.

Authors:  Yongchao Wang; Sangmi Kim; Il-Man Kim
Journal:  Front Oncol       Date:  2014-06-10       Impact factor: 6.244

9.  Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway.

Authors:  Wei Li; Jing Wang; Qiu-Dan Chen; Xu Qian; Qi Li; Yu Yin; Zhu-Mei Shi; Lin Wang; Jie Lin; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

10.  Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.

Authors:  Annette R Kodahl; Pernille Zeuthen; Harald Binder; Ann S Knoop; Henrik J Ditzel
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more
  16 in total

Review 1.  The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

2.  miR-338-3p blocks TGFβ-induced myofibroblast differentiation through the induction of PTEN.

Authors:  Ashley R Rackow; Jennifer L Judge; Collynn F Woeller; Patricia J Sime; Robert M Kottmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-01-05       Impact factor: 5.464

3.  Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR.

Authors:  Fuxing Tang; Xiaohong Jiang; Shijie Liao; Yun Liu; Maolin He
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

4.  MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

Authors:  Guo-Qing Sui; Dan Fei; Feng Guo; Xi Zhen; Qiang Luo; Shuai Yin; Hui Wang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

5.  CircHIPK2 Contributes to DDP Resistance and Malignant Behaviors of DDP-Resistant Ovarian Cancer Cells Both in vitro and in vivo Through circHIPK2/miR-338-3p/CHTOP ceRNA Pathway.

Authors:  Yang Cao; Xin Xie; Mingzhu Li; Yuhua Gao
Journal:  Onco Targets Ther       Date:  2021-05-13       Impact factor: 4.147

6.  MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.

Authors:  Qin Niu; Zhenghong Liu; Jia Gao; Qiao Wang
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

7.  microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1.

Authors:  Riliang Cao; Jianli Shao; Yabin Hu; Liang Wang; Zhizhong Li; Guodong Sun; Xiaoliang Gao
Journal:  Cancer Cell Int       Date:  2018-04-02       Impact factor: 5.722

Review 8.  MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers.

Authors:  Jin Ye; Manman Zou; Pei Li; Hui Liu
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

9.  LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.

Authors:  Xiaotian Luan; Yankui Wang
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

10.  CircHIPK3 Facilitates the G2/M Transition in Prostate Cancer Cells by Sponging miR-338-3p.

Authors:  Fengchun Liu; Yanru Fan; Liping Ou; Ting Li; Jiaxin Fan; Limei Duan; Jinxiao Yang; Chunli Luo; Xiaohou Wu
Journal:  Onco Targets Ther       Date:  2020-05-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.